Parkinson's Disease Is . . .

. . . Growing
According to the National Parkinson's Foundation, Parkinson's disease affects approximately 1 million Americans. As the global population continues to age, the incidence of Parkinson's disease in persons over 60 is expected to increase. At the same time, however, the American Parkinson's Disease Society has reported that the incidence among persons under 50 is also on the rise.

. . . Debilitating
Parkinson's disease is a progressive neurodegenerative disease in which patients are unable to produce enough dopamine in the brain. Dopamine, a chemical necessary for normal movement, is produced in the dopaminergic neurons in the base of the brain. Parkinson's disease slowly destroys these dopamine-producing neurons over time, causing a wide variety of symptoms including tremors, rigidity, slowness of movement, uncontrolled muscle movement, speech disorders, and gait and postural disturbances.

. . . Treatable
While there is no cure for Parkinson's disease, Aderis Pharmaceuticals is committed to helping Parkinson's patients control their symptoms and live more normal lives. Rotigotine - a once-a-day skin patch is being developed and commercialized by our partner, Schwarz Pharma AG, to effectively treat the symptoms of Parkinson's disease while avoiding the side effects caused by current oral medications. For more information on this novel product currently in development, click here.

For a list of websites providing information on Parkinson's disease, click here.

back to top

---